Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 193 (1) , 65-74
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington diseaseMolecular Therapy, 2004
- Exploratory Activity and Fear Conditioning Abnormalities Develop Early in R6/2 Huntington's Disease Transgenic Mice.Behavioral Neuroscience, 2003
- Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease MiceNeurobiology of Disease, 2002
- Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's DiseaseJournal of Neurochemistry, 2000
- Intracerebral Implantation of NGF-Releasing Biodegradable Microspheres Protects Striatum against Excitotoxic DamageExperimental Neurology, 2000
- Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene TransferHuman Gene Therapy, 1999
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Huntington's disease: translating a CAG repeat into a pathogenic mechanismCurrent Opinion in Neurobiology, 1996
- Implants of polymer‐encapsulated human NGF‐secreting cells in the nonhuman primate: Rescue and sprouting of degenerating cholinergic basal forebrain neuronsJournal of Comparative Neurology, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993